Cite
HARVARD Citation
Bergvall, N. et al. (n.d.). Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis. Current medical research and opinion. pp. 1461-1471. [Online].